CN106974265A - A kind of enteral nutritional composition - Google Patents
A kind of enteral nutritional composition Download PDFInfo
- Publication number
- CN106974265A CN106974265A CN201710034103.3A CN201710034103A CN106974265A CN 106974265 A CN106974265 A CN 106974265A CN 201710034103 A CN201710034103 A CN 201710034103A CN 106974265 A CN106974265 A CN 106974265A
- Authority
- CN
- China
- Prior art keywords
- nutritional composition
- enteral nutritional
- cellulose
- composition according
- enteral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 72
- 239000000203 mixture Substances 0.000 title claims abstract description 37
- 230000035764 nutrition Effects 0.000 claims abstract description 40
- 229920002678 cellulose Polymers 0.000 claims abstract description 22
- 239000001913 cellulose Substances 0.000 claims abstract description 22
- 239000000084 colloidal system Substances 0.000 claims abstract description 19
- 235000010980 cellulose Nutrition 0.000 claims description 20
- 229920002148 Gellan gum Polymers 0.000 claims description 10
- 235000010492 gellan gum Nutrition 0.000 claims description 10
- 239000000216 gellan gum Substances 0.000 claims description 10
- 239000000725 suspension Substances 0.000 claims description 9
- 244000068988 Glycine max Species 0.000 claims description 8
- 235000010469 Glycine max Nutrition 0.000 claims description 8
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 8
- -1 sucrose fatty ester Chemical class 0.000 claims description 8
- 241000206575 Chondrus crispus Species 0.000 claims description 7
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 7
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 7
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 7
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 7
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 7
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 7
- 239000003921 oil Substances 0.000 claims description 7
- 229920001285 xanthan gum Polymers 0.000 claims description 7
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 6
- 239000011575 calcium Substances 0.000 claims description 6
- 229910052791 calcium Inorganic materials 0.000 claims description 6
- 239000000835 fiber Substances 0.000 claims description 6
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 6
- 239000011707 mineral Substances 0.000 claims description 6
- 229920001277 pectin Polymers 0.000 claims description 6
- 235000010987 pectin Nutrition 0.000 claims description 6
- 239000001814 pectin Substances 0.000 claims description 6
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 6
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 108090000623 proteins and genes Proteins 0.000 claims description 5
- 102000004169 proteins and genes Human genes 0.000 claims description 5
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 4
- 239000011651 chromium Substances 0.000 claims description 4
- 229910052804 chromium Inorganic materials 0.000 claims description 4
- 239000003995 emulsifying agent Substances 0.000 claims description 4
- 229910052742 iron Inorganic materials 0.000 claims description 4
- 239000011777 magnesium Substances 0.000 claims description 4
- 229910052749 magnesium Inorganic materials 0.000 claims description 4
- 239000011701 zinc Substances 0.000 claims description 4
- 229910052725 zinc Inorganic materials 0.000 claims description 4
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims description 3
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 3
- 229920001817 Agar Polymers 0.000 claims description 3
- 241000416162 Astragalus gummifer Species 0.000 claims description 3
- 239000001856 Ethyl cellulose Substances 0.000 claims description 3
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims description 3
- 229920001503 Glucan Polymers 0.000 claims description 3
- 229920002907 Guar gum Polymers 0.000 claims description 3
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 3
- 229920000161 Locust bean gum Polymers 0.000 claims description 3
- 229920002125 Sokalan® Polymers 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 3
- 229920001615 Tragacanth Polymers 0.000 claims description 3
- 235000010489 acacia gum Nutrition 0.000 claims description 3
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims description 3
- 239000008272 agar Substances 0.000 claims description 3
- 235000010419 agar Nutrition 0.000 claims description 3
- 159000000007 calcium salts Chemical class 0.000 claims description 3
- 235000019325 ethyl cellulose Nutrition 0.000 claims description 3
- 229920001249 ethyl cellulose Polymers 0.000 claims description 3
- 235000010417 guar gum Nutrition 0.000 claims description 3
- 239000000665 guar gum Substances 0.000 claims description 3
- 229960002154 guar gum Drugs 0.000 claims description 3
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 3
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 3
- 235000010420 locust bean gum Nutrition 0.000 claims description 3
- 239000000711 locust bean gum Substances 0.000 claims description 3
- 229920000609 methyl cellulose Polymers 0.000 claims description 3
- 239000001923 methylcellulose Substances 0.000 claims description 3
- 235000010981 methylcellulose Nutrition 0.000 claims description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 3
- 235000010413 sodium alginate Nutrition 0.000 claims description 3
- 239000000661 sodium alginate Substances 0.000 claims description 3
- 229940005550 sodium alginate Drugs 0.000 claims description 3
- 229940083466 soybean lecithin Drugs 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- 235000010487 tragacanth Nutrition 0.000 claims description 3
- 239000000196 tragacanth Substances 0.000 claims description 3
- 229940116362 tragacanth Drugs 0.000 claims description 3
- CODAYFPFZXWNLD-UHFFFAOYSA-N 2-hydroxypropanoyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(=O)C(C)O CODAYFPFZXWNLD-UHFFFAOYSA-N 0.000 claims description 2
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 claims description 2
- 244000100170 Phaseolus lunatus Species 0.000 claims description 2
- 235000010617 Phaseolus lunatus Nutrition 0.000 claims description 2
- 235000021355 Stearic acid Nutrition 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- 239000000839 emulsion Substances 0.000 claims description 2
- 239000003292 glue Substances 0.000 claims description 2
- 125000005456 glyceride group Chemical group 0.000 claims description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 239000008117 stearic acid Substances 0.000 claims description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 claims 1
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 claims 1
- 239000000600 sorbitol Substances 0.000 claims 1
- 239000008187 granular material Substances 0.000 abstract 1
- 239000000047 product Substances 0.000 description 42
- 239000003381 stabilizer Substances 0.000 description 22
- 230000014759 maintenance of location Effects 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- 150000002500 ions Chemical class 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 235000015424 sodium Nutrition 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- 230000001133 acceleration Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
- 230000006641 stabilisation Effects 0.000 description 4
- 238000011105 stabilization Methods 0.000 description 4
- 239000000375 suspending agent Substances 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 3
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 3
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 3
- 235000013325 dietary fiber Nutrition 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 229960000304 folic acid Drugs 0.000 description 3
- 235000019152 folic acid Nutrition 0.000 description 3
- 239000011724 folic acid Substances 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 229910052750 molybdenum Inorganic materials 0.000 description 3
- 239000011733 molybdenum Substances 0.000 description 3
- 229960003966 nicotinamide Drugs 0.000 description 3
- 239000011570 nicotinamide Substances 0.000 description 3
- 235000005152 nicotinamide Nutrition 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 229960002477 riboflavin Drugs 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 3
- 239000011691 vitamin B1 Substances 0.000 description 3
- 239000011715 vitamin B12 Substances 0.000 description 3
- 239000011726 vitamin B6 Substances 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 2
- WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCC(C)CC2)C=C1 WIGIZIANZCJQQY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 229920001202 Inulin Polymers 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- CPLXHLVBOLITMK-UHFFFAOYSA-N Magnesium oxide Chemical compound [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 2
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- XWCYDHJOKKGVHC-UHFFFAOYSA-N Vitamin A2 Chemical compound OCC=C(C)C=CC=C(C)C=CC1=C(C)C=CCC1(C)C XWCYDHJOKKGVHC-UHFFFAOYSA-N 0.000 description 2
- 229930003451 Vitamin B1 Natural products 0.000 description 2
- 229930003779 Vitamin B12 Natural products 0.000 description 2
- 229930003471 Vitamin B2 Natural products 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 235000010216 calcium carbonate Nutrition 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 210000003022 colostrum Anatomy 0.000 description 2
- 235000021277 colostrum Nutrition 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 2
- 229940029339 inulin Drugs 0.000 description 2
- 239000011572 manganese Substances 0.000 description 2
- 229910052748 manganese Inorganic materials 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 229940055726 pantothenic acid Drugs 0.000 description 2
- 235000019161 pantothenic acid Nutrition 0.000 description 2
- 239000011713 pantothenic acid Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011772 phylloquinone Substances 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229960003975 potassium Drugs 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 229940091258 selenium supplement Drugs 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 230000009469 supplementation Effects 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- 235000019731 tricalcium phosphate Nutrition 0.000 description 2
- 229940078499 tricalcium phosphate Drugs 0.000 description 2
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 235000019163 vitamin B12 Nutrition 0.000 description 2
- 235000019164 vitamin B2 Nutrition 0.000 description 2
- 239000011716 vitamin B2 Substances 0.000 description 2
- 235000019158 vitamin B6 Nutrition 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 1
- 108010022579 ATP dependent 26S protease Proteins 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 235000019743 Choline chloride Nutrition 0.000 description 1
- 229910021555 Chromium Chloride Inorganic materials 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 102000004407 Lactalbumin Human genes 0.000 description 1
- 108090000942 Lactalbumin Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 229910021380 Manganese Chloride Inorganic materials 0.000 description 1
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 1
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- FCASKLHVRFDIJB-UHFFFAOYSA-N Riboflavine Natural products Cc1cc2N=C3C(NC(=O)NC3=O)N(CC(O)C(O)C(O)CO)c2cc1C FCASKLHVRFDIJB-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- DPRNENKPXAZQBI-UHFFFAOYSA-N alpha-Vitamin A Natural products OCC=C(C)C=CC=C(C)C=CC1C(C)=CCCC1(C)C DPRNENKPXAZQBI-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960003563 calcium carbonate Drugs 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229960003178 choline chloride Drugs 0.000 description 1
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 1
- QSWDMMVNRMROPK-UHFFFAOYSA-K chromium(3+) trichloride Chemical compound [Cl-].[Cl-].[Cl-].[Cr+3] QSWDMMVNRMROPK-UHFFFAOYSA-K 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000011706 ferric diphosphate Substances 0.000 description 1
- 235000007144 ferric diphosphate Nutrition 0.000 description 1
- CADNYOZXMIKYPR-UHFFFAOYSA-B ferric pyrophosphate Chemical compound [Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O CADNYOZXMIKYPR-UHFFFAOYSA-B 0.000 description 1
- 229940036404 ferric pyrophosphate Drugs 0.000 description 1
- 229940050549 fiber Drugs 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 238000005189 flocculation Methods 0.000 description 1
- 230000016615 flocculation Effects 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- XMBWDFGMSWQBCA-LZFNBGRKSA-N iodane Chemical compound [133IH] XMBWDFGMSWQBCA-LZFNBGRKSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 229960002337 magnesium chloride Drugs 0.000 description 1
- 235000011147 magnesium chloride Nutrition 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- 235000012245 magnesium oxide Nutrition 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 239000011565 manganese chloride Substances 0.000 description 1
- 235000002867 manganese chloride Nutrition 0.000 description 1
- 229940099607 manganese chloride Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- 235000016236 parenteral nutrition Nutrition 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 description 1
- 235000019175 phylloquinone Nutrition 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229960001898 phytomenadione Drugs 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 229960002816 potassium chloride Drugs 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Substances [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000006920 protein precipitation Effects 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 229940083542 sodium Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229960002668 sodium chloride Drugs 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 229960000414 sodium fluoride Drugs 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to a kind of enteral nutritional composition.Specifically, enteral nutritional composition of the present invention contains colloid and cellulose.Colloid and cellulose can make the insoluble granule in enteral nutrition product keep suspending, prevent it from settling or luming.Enteral nutritional composition stability of the present invention is improved significantly.
Description
Technical field
The invention belongs to field of pharmaceutical preparations, it is related to a kind of enteral nutritional composition.
Background technology
Enteral nutrition is a kind of nutrition branch for being provided through intestines and stomach and being metabolized the nutriment needed and other various nutrients
Hold mode.With going deep into recent years to intestines and stomach 26S Proteasome Structure and Function research, people progressively recognize that intestines and stomach do not disappear merely
Change and absorb organ, while being important immune organ.Just because of this, than Parenteral nutrition, the superiority of enteral nutrition
Except be embodied in nutrient directly through intestinal absorption, utilize, more accord with physiology, convenient drug administration, low-cost outer, more display helps to maintain
The advantage of intestinal mucosa structure and integrality of barrier function.Therefore when determining to provide which kind of nutritional support mode, preferred enteral nutrition
Turn into the common recognition of numerous clinicians.
The different enteral nutrition product of a variety of compositions, some of list marketings, such as CN1439298A are reported
Disclosed enteral nutrition product, is listed with the auspicious element of trade name;CN1439299A discloses another enteral nutrition product, its
It can be listed so that trade name is auspicious;CN1122457C is disclosed the product also disclosed that and also listed with all strength with trade name health;
Separately there is CN101027074 to also disclose that a kind of enteral nutrition product.
As the enteral nutrition product for providing whole nutrition or nutritional supplementation, often by protein, carbohydrate, fat
Nutrition is constituted necessary to the human bodies such as fat, fiber, mineral matter, trace element, vitamin.Because composition is extremely complex, cause
In system in addition to the solution being made up of water-soluble composition and the emulsion droplet largely existed, also water insoluble material is deposited
.Such as insoluble calcium salt (tricalcium phosphate, calcium carbonate, calcium hydroxide etc.), insoluble soybean polyoses or soybean fiber, very
As for a small amount of protein precipitation produced by technique.If this part insoluble substance can not be suspended among system, can
Slowly assemble, be deposited in product bottom.
Because the commercially available enteral nutrition product shelf-life is longer, up to even 2 years a year and a half, therefore sedimentation problem was aobvious
Obtain particularly evident.In general, standing time is longer, precipitates more, degree of scatter poorer., can when as the nutritional supplementation used time
It can not enough cause precipitation scattered incomplete because of shaking dynamics, can if things go on like this cause patient part's nutrient supplement not enough
(such as calcium constituent), it is particularly evident that this embodies in the patient for needing full nutrition treatment.Therefore the steady of enteral nutrition product is improved
Qualitative is very necessary.
For supensoid agent, stabilizer or suspending agent are often added, by increasing the viscosity of system, reduction medicine is micro-
The sinking speed of grain, is attracted to microparticle surfaces formation diaphragm and hinders the means such as particulate merging and flocculation to reach improvement system
Physical stability purpose.
Suspending agent is generally divided into low molecule suspending agent (such as glycerine) and polymeric retention aid suspension.Polymeric retention aid suspension is divided into day again
Right polymeric retention aid suspension such as Arabic gum, tragacanth, xanthans, carragheen, sodium alginate, agar, starch slurry etc., are commonly called as
Colloidal type;Synthesis or semi-synthetic polymeric retention aid suspension, such as methylcellulose, ethyl cellulose, sodium carboxymethylcellulose, crystallite are fine
Element, hydroxypropyl cellulose, carbopol, PVP, glucan etc. are tieed up, cellulose family is commonly called as.
We have found that colloidal type stabilizer and cellulose family stabilization are used alone in the enteral nutrition product of complicated
Agent can not play stabilization well, or even can occur serious consistency problem.Due to being rich in enteral nutrition product
Mineral matter, such as monovalent ion Na+、K+、Cl-、F-、I-, divalent ion Ca2+、Zn2+、Mg2+、Cu2+、Mn2+、SO4 2-, trivalent ion
Fe3+、Cr3+、PO4 3-Deng.Cellulose family stabilizer is used alone can be due to not being resistant to ion higher in enteral nutrition product
Concentration, causes its compatibility with system poor, product is flocculated.And the sample for using single colloidal type suspending agent to prepare
Product outward appearance is slightly poor, the phenomenons such as floating oil and layering occurs.Therefore, pole need to solve the sedimentation of insoluble substance in enteral nutritional composition
Problem, improves its stability.
The content of the invention
It is an object of the invention to provide a kind of enteral nutritional composition of stabilization.
Enteral nutritional composition of the present invention, contains colloid and cellulose.
The addition of colloid and cellulose, improves the stability of composition, so as to solve because insoluble in enteral nutrition product
Property species precipitate and cause the problem of nutrient supplement is not enough.
The colloid that the present invention is used can be selected from the one or more of following material:Arabic gum, tragacanth, xanthan
Glue, carragheen, pectin, locust bean gum, guar gum, gellan gum, sodium alginate, agar.It preferably is selected from carragheen, pectin, gellan gum
With the one or more in xanthans.
In the most preferred embodiment of the present invention, the colloid is gellan gum.
The content of the colloid is unrestricted, as long as containing a small amount of above-mentioned colloid, you can play stable effect.In order to make
The convenience of agent, in a preferred embodiment of the present invention, the content range of the colloid can be total based on enteral nutrition product
Weight meter is no more than 0.2%;It is preferred that 0.0025-0.15%;More preferably 0.005-0.1%;Most preferably 0.01-0.05%.
The cellulose that the present invention is used can be selected from the one or more of following material:Methylcellulose, ethyl cellulose,
Sodium carboxymethylcellulose, microcrystalline cellulose, hydroxypropyl cellulose, carbopol, PVP, glucan etc..It is preferred that carboxymethyl cellulose
One or more in plain sodium or microcrystalline cellulose.In a preferred embodiment of the present invention, rising surely used in the present invention
Tailor-made cellulose, which does not include soybean dietary fiber, inulin often used in enteral nutritional composition etc., to be used to supplement human body institute
Those nutritional ingredients of cellulose are needed, these compositions are used mainly as nutritional ingredient, it can not play stabilization or steady
Determine effect not good.
In a preferred embodiment of the present invention, described enteral nutritional composition, it contains mineral matter.It is wherein described
Mineral matter can contain the one or more in calcium, magnesium, zinc, iron, manganese, chromium.
In presently preferred embodiment, it contains many selected from insoluble calcium salt, insoluble soybean
Sugar or soybean fiber, protein in any one or a few.
The content range of the cellulose is not particularly limited, and can be based on enteral nutrition product gross weight meter
0.005%-0.2%;It is preferred that 0.01%-0.15%;Most preferably 0.015-0.1%.
Enteral nutritional composition of the present invention can contain emulsifying agent, such as soybean lecithin, single double glycerol stearates
Ester, sucrose fatty ester, stearoyl lactate, diacetyl tartarate list double glyceride, Tween-80
Deng one or more.Based on enteral nutrition product gross weight, the emulsifier content is about 0.05%~2%.
Enteral nutritional composition of the present invention, in addition to adding colloid and cellulose, remaining nutritional ingredient is conventional
Needed by human body composition.As an exemplary example, composition of the invention can also contain in addition to colloid and cellulose
Following composition:
Protein | 46.8-70.2g | Molybdenum | 80-120 μ g |
Fat | 57.6-86.4g | Selenium | 53.6-80.4 μ g |
Carbohydrate | 83.2-124.8g | Vitamin A | 1.6-4.2mg |
Dietary fiber | 9-15.6g | Vitamine D3 | 3.68-7.50 μ g |
Sodium | 0.64-1.06g | Vitamin E | 21.6-44.0mg |
Potassium | 1.376-2.194_g | Vitamin K1 | 52.8-145.0 μ g |
Chloride | 0.992-1.488_g | Vitamin B1 | 1.04-2.10mg |
Calcium | 400-700mg | Vitamin B2 | 1.36-3.00mg |
Phosphorus | 400-700mg | Niacinamide | 9.6-16.2mg |
Magnesium | 176-264mg | Vitamin B6 | 1.28-2.65mg |
Iron | 10.4-15.6mg | Vitamin B12 | 2.08-4.95 μ g |
Zinc | 8-12mg | Pantothenic acid | 3-68-6.95mg |
Copper | 0.9-1.7mg | Biotin | 104-190 μ g |
Manganese | 1.9-3.5mg | Folic acid | 104-215 μ g |
Iodide | 106.4-159.6 μ g | Vitamin C | 70-700mg |
Fluoride | L.04-1.56mg | Choline | 212.8-319.2mg |
Chromium | 52.8-79.2 μ g |
As another exemplary example, composition of the present invention, can also be containing such as in addition to colloid and cellulose
Lower composition:
Enteral nutritional composition of the present invention solves the settlement issues of insoluble substance, and compatibility is good.Together
When compared to single type stabilizer is used, it is less using the consumption of stabilizer during compound stabilizer, that is, save cost, reduction adds
Plus influence of the agent to patient, be conducive to industrialized production again.
Embodiment
The present invention is further described by following examples and comparative example.These embodiments and comparative example are only used for
Bright property purpose, and the scope being not intended to limit the invention.
Comparative example 1
In order to investigate influence of the stabilizer to enteral nutrition product stability, the enteral nutrition for being added without stabilizer is devised
The basic prescription of product, wherein containing protein 58.5g, carbohydrate 104g, lipase 37 2g, dietary fiber 13g, sodium 800mg,
Potassium 1.72g, chlorine 1.24g, calcium 500mg, phosphorus 500mg, magnesium 220mg, iron 13mg, zinc 10mg, copper 1.3mg, manganese 2.7mg, the μ of iodine 133
G, fluorine 1.3mg, the μ g of chromium 66, molybdenum 0.1mg, the μ g of selenium 67, dehydroretinol mg, the μ g of vitamine D3 4.6, vitamin E 27mg, vitamin
The μ g of K 66, vitamin B1 1.3mg, vitamin B2 1.7mg, niacinamide 12mg, vitamin B6 1.6mg, the μ of vitamin B12 2.6
G, pantothenic acid 4.6mg, biotin 0.13mg, folic acid 0.13mg, vitamin C 80mg, choline 266mg, purified water add to 1000ml.
The specific formula that feeds intake is as follows:
In preparing tank add total amount be 600-750g purified water, start stirring after add thereto casein sodium,
Lactalbumin, maltodextrin, sucrose, DEXTROSE ANHYDROUS, lactose, soybean fiber, inulin, sodium chloride, potassium citrate, potassium chloride,
Tricalcium phosphate, calcium carbonate, magnesia, magnesium chloride, ferric pyrophosphate, zinc sulfate, copper sulphate, manganese chloride, KI, chromium chloride, molybdenum
Sour sodium, sodium selenite, sodium fluoride, vitamin D3Dry powder, vitamin C, vitamin B1, Riboflavine sodium phosphate, niacinamide, D-VB5
Calcium, vitamin B6, folic acid, vitamin B12, Bio, Choline Chloride, mixed fruit essence, its fully dispersed dissolving is made
For aqueous phase.Fish oil, linseed oil, sunflower oil, safflower seed oil, median chain triglyceride oil, soybean lecithin, single double stearic acid are sweet
Grease, Retinol Palmitate, vitamin E, vitamin K1Dispersing and dissolving, is used as oil phase in a shear condition.By oil phase and water
Mixing shearing is mutually carried out, colostrum is prepared.The purified water of surplus is added into colostrum, stirring is removed and defoamed.After will be except defoaming
Mixed liquor by homogenizer carry out homogeneous, be cooled to afterwards room temperature enter stand tank preserve, will stand tank Chinese medicine liquid automatic
It is filled on bottle placer in Brown Glass Brown glass bottles and jars only and nitrogen charging, rolls lid.Packaged bottled product is placed in rotary water-bath sterilizer
Middle to be sterilized, 120-122 DEG C of temperature, F0 values can obtain enteral nutrition product in 10-20 minutes.
Embodiment 1~7
In order to investigate influence of the stabilizer to enteral nutrition product stability, on the basis of above-mentioned enteral nutrition product prescription
(be added without any stabilizer for comparative example 1) adds different natural polymeric retention aid suspensions as stabilizer, and prescription is shown in Table 1.
Table 1 adds the enteral nutrition product 1L prescriptions of different natural polymeric retention aid suspensions
Enteral nutrition product is investigated using appearance character, viscosity as index.Wherein viscosity measurement is as follows:Sample is light
After light shaking, measured with Brookfield rotation viscometers, temperature is 20 DEG C, using No. 61 rotors 100rpm condition
It is lower to determine.Each sample is placed 1M further to investigate its stability under 40 DEG C of acceleration environments, 2 are the results are shown in Table.In this table, with
And in the form of the application hereinafter, the number for a certain character "+" number illustrates its order of severity, specifically, example
Such as precipitation, ++++﹥ +++ ﹥ ++ ﹥+.
The enteral nutrition product evaluation index and result of the different prescriptions of table 2
As can be seen from Table 2, when not adding stabilizer, there is obvious floating oil and heavy after placing 1M at 40 degree in product
Form sediment.After colloid is added as stabilizer, although floating oil slightly improves with precipitation, the feelings incompatible with system are also occurred in that
Condition, such as the system for adding xanthans occurs in that layering.In addition it is used as stabilizer containing carragheen, locust bean gum, guar gum
Product occur in that a small amount of blob of viscose, show that the amount for adding stabilizer is higher, but still sunk in the case of such a higher concentration
Form sediment.Only pectin, gellan gum effect are slightly good.
Embodiment 8~14
Different synthesis or semi-synthetic polymeric retention aid suspension are added on the basis of comparative example as stabilizer, 3 are specifically shown in Table.
Table 3 adds the enteral nutrition product 1L prescriptions of different synthesis or semi-synthetic polymeric retention aid suspension
Enteral nutrition product is investigated using appearance character as index, each sample is placed 1M to enter under 40 DEG C of acceleration environments
One step investigates its stability, the results are shown in Table 4.
The enteral nutrition product evaluation index and result of the different prescriptions of table 4
As can be seen from Table 4, individually using cellulose family stabilizer to prepare sample effect poor, flocculates, table
Light fibers element class stabilizer and Miscibility are poor.Analysis reason be such stabilizer be not resistant in enteral nutrition product compared with
Caused by high ion concentration.
Embodiment 15~22
Gellan gum, pectin, xanthans, carragheen, microcrystalline cellulose and sodium carboxymethylcellulose are mixed according to following table and made
TPF product is prepared for stabilizer, 5 are specifically shown in Table.Investigated using appearance character as index, and by each sample
Place 1M under 40 DEG C of acceleration environments further to investigate its stability, stability result is shown in Table 6.
The colloid of different proportion is constituted with cellulose in the enteral nutrition product 1L of table 5
The enteral nutrition product evaluation index and result of the different prescriptions of table 6
Embodiment 23~31
Gellan gum, microcrystalline cellulose, sodium carboxymethylcellulose are mixed as stabilizer using certain proportion, enteral battalion is prepared
Product is supported, 7 are specifically shown in Table.Investigated using appearance character as index, and each sample is placed into 1M under 40 DEG C of acceleration environments
Further to investigate its stability, stability result is shown in Table 8.
The gellan gum of different proportion is constituted with cellulose in the enteral nutrition product 1L of table 7
The enteral nutrition product evaluation index and result of the different prescriptions of table 8
As can be seen from Table 8, gellan gum is mixed with microcrystalline cellulose, sodium carboxymethylcellulose with certain proportion
Afterwards, the stability of product can be obviously improved, and compatibility is good.Colloid is combined after use with cellulose, stabilizer is total
Amount is significantly reduced, but stability is good.
Comparative example 1 and the product of embodiment 29 (must not be freezed into) closed preservation 12M below 25 DEG C.As a result such as table 9 below institute
Show.
The comparative example 1 of table 9 with the product of embodiment 29 is closed preserve 12 months after assay
Claims (12)
1. a kind of enteral nutritional composition, it is characterised in that contain colloid and cellulose.
2. enteral nutritional composition according to claim 1, described colloid is selected from Arabic gum, tragacanth, xanthan
One or more in glue, carragheen, pectin, locust bean gum, guar gum, gellan gum, sodium alginate, agar, preferably carragheen,
One or more in pectin, gellan gum and xanthans.
3. enteral nutritional composition according to claim 1, described cellulose is selected from methylcellulose, ethyl cellulose
One or more in element, sodium carboxymethylcellulose, microcrystalline cellulose, hydroxypropyl cellulose, carbopol, PVP, glucan,
One or more in preferably carboxymethyl cellulose sodium or microcrystalline cellulose.
4. enteral nutritional composition according to claim 1 or 2, wherein the content of the colloid is combined based on enteral nutrition
Thing gross weight meter is no more than 0.2%;It is preferred that 0.0025-0.15%;More preferably 0.005-0.1%;Most preferably 0.01-0.05%.
5. the enteral nutritional composition according to claim 1 or 3, wherein the content of the cellulose is based on enteral nutrition group
Compound gross weight meter is 0.005%-0.2%;It is preferred that 0.01%-0.15%;Most preferably 0.015-0.1%.
6. enteral nutritional composition according to claim 1, it contains mineral matter.
7. enteral nutritional composition according to claim 6, wherein described mineral matter contain selected from calcium, magnesium, zinc, iron,
One or more in manganese, chromium.
8. enteral nutritional composition according to claim 1, it contains many selected from insoluble calcium salt, insoluble soybean
Sugar or soybean fiber, protein in any one or a few.
9. enteral nutritional composition according to claim 1, it contains emulsifying agent, preferably soybean lecithin, single double stearic acid
Glyceride, sucrose fatty ester, stearoyl lactate, diacetyl tartarate list double glyceride, polyoxyethylene sorbitol acid anhydride list oil
The one or more such as acid esters.
10. enteral nutritional composition according to claim 9, the emulsifier content about 0.05%~2%.
11. the enteral nutritional composition according to claim any one of 1-10, the composition is emulsion, suspension, powder
Agent or granular form.
12. a kind of improve the method for enteral nutritional composition stability, it is characterised in that adds any one of claim 1-5 institute
The colloid and cellulose stated.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610035649 | 2016-01-19 | ||
CN2016100356496 | 2016-01-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106974265A true CN106974265A (en) | 2017-07-25 |
Family
ID=59340830
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710034103.3A Pending CN106974265A (en) | 2016-01-19 | 2017-01-17 | A kind of enteral nutritional composition |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106974265A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109674038A (en) * | 2017-10-19 | 2019-04-26 | 江苏正大丰海制药有限公司 | A kind of oral complete nutritional composition |
CN110973644A (en) * | 2019-12-16 | 2020-04-10 | 广州白云山汉方现代药业有限公司 | Casein and whey protein compounded nutritional suspension and preparation thereof |
CN113795565A (en) * | 2019-03-29 | 2021-12-14 | 切尔西科技有限公司 | Tracer compositions |
CN114365841A (en) * | 2021-12-15 | 2022-04-19 | 北京诺康达医药科技股份有限公司 | Total nutrient milk suitable for patients with nephropathy and preparation method thereof |
Citations (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5376396A (en) * | 1993-04-27 | 1994-12-27 | Merck & Co., Inc. | Beverage stabilizing system and process thereof |
WO1999056563A2 (en) * | 1998-05-07 | 1999-11-11 | Abbott Laboratories | NUTRITIONALLY COMPLETE LOW pH ENTERAL FORMULA |
CN1374838A (en) * | 1999-04-14 | 2002-10-16 | 雀巢制品公司 | Method for stabilizing liquid nutritional products and products so stabilized |
CN1660406A (en) * | 2004-12-16 | 2005-08-31 | 广东省农业科学院农业生物技术研究所 | Short peptide type nutriend emulsion inside bowel and producing method |
US20050233046A1 (en) * | 2004-04-05 | 2005-10-20 | Fmc Corporation | MCC/hydrocolloid stabilizers and edible compositions comprising the same |
CN101001532A (en) * | 2004-04-05 | 2007-07-18 | Fmc有限公司 | MCC/hydrocolloid stabilizers and edible compositions comprising the same |
CN101027074A (en) * | 2004-09-22 | 2007-08-29 | 味之素株式会社 | Total enteral nutritious composition |
JP2008118988A (en) * | 2006-10-16 | 2008-05-29 | Asahi Kasei Chemicals Corp | Heat-resistant gelling agent |
CN101278736A (en) * | 2008-03-28 | 2008-10-08 | 西安力邦制药有限公司 | Balanced enteral total nutrient preparation suitable for nutrition support of Asian population |
CN100451035C (en) * | 2002-07-12 | 2009-01-14 | 旭化成株式会社 | Water-dispersible cellulose and process for producing the same |
KR20120061162A (en) * | 2010-12-02 | 2012-06-13 | 대상 주식회사 | Beverage composition with improved stability and reduced browning |
CN102834447A (en) * | 2010-03-31 | 2012-12-19 | 旭化成化学株式会社 | Cellulose composite |
CN103025178A (en) * | 2010-04-26 | 2013-04-03 | 雀巢产品技术援助有限公司 | Nutritional compositions and methods for weaning from parenteral nutrition to enteral nutrition |
CN103748115A (en) * | 2011-08-11 | 2014-04-23 | 旭化成化学株式会社 | Highly functional cellulose composite |
CN104114037A (en) * | 2012-02-14 | 2014-10-22 | 旭化成化学株式会社 | Cellulose composition |
CN104686667A (en) * | 2013-12-06 | 2015-06-10 | 内蒙古伊利实业集团股份有限公司 | Cereal milky beverage and preparation method thereof |
WO2015177145A1 (en) * | 2014-05-22 | 2015-11-26 | Nestec S.A. | Low-sugar dairy beverages |
CN105455133A (en) * | 2015-12-08 | 2016-04-06 | 西安力邦临床营养股份有限公司 | Predigestion type total nutrient solution and preparation method thereof |
CN105559050A (en) * | 2015-12-09 | 2016-05-11 | 南通励成生物工程有限公司 | Protolysate-based liquid food and preparation method |
-
2017
- 2017-01-17 CN CN201710034103.3A patent/CN106974265A/en active Pending
Patent Citations (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5376396A (en) * | 1993-04-27 | 1994-12-27 | Merck & Co., Inc. | Beverage stabilizing system and process thereof |
WO1999056563A2 (en) * | 1998-05-07 | 1999-11-11 | Abbott Laboratories | NUTRITIONALLY COMPLETE LOW pH ENTERAL FORMULA |
US6475539B1 (en) * | 1998-05-07 | 2002-11-05 | Abbott Laboratories | Nutritionally complete low pH enteral formula |
CN1374838A (en) * | 1999-04-14 | 2002-10-16 | 雀巢制品公司 | Method for stabilizing liquid nutritional products and products so stabilized |
CN100451035C (en) * | 2002-07-12 | 2009-01-14 | 旭化成株式会社 | Water-dispersible cellulose and process for producing the same |
US20050233046A1 (en) * | 2004-04-05 | 2005-10-20 | Fmc Corporation | MCC/hydrocolloid stabilizers and edible compositions comprising the same |
CN101001532A (en) * | 2004-04-05 | 2007-07-18 | Fmc有限公司 | MCC/hydrocolloid stabilizers and edible compositions comprising the same |
CN101027074A (en) * | 2004-09-22 | 2007-08-29 | 味之素株式会社 | Total enteral nutritious composition |
CN1660406A (en) * | 2004-12-16 | 2005-08-31 | 广东省农业科学院农业生物技术研究所 | Short peptide type nutriend emulsion inside bowel and producing method |
JP2008118988A (en) * | 2006-10-16 | 2008-05-29 | Asahi Kasei Chemicals Corp | Heat-resistant gelling agent |
CN101278736A (en) * | 2008-03-28 | 2008-10-08 | 西安力邦制药有限公司 | Balanced enteral total nutrient preparation suitable for nutrition support of Asian population |
CN102834447A (en) * | 2010-03-31 | 2012-12-19 | 旭化成化学株式会社 | Cellulose composite |
CN103025178A (en) * | 2010-04-26 | 2013-04-03 | 雀巢产品技术援助有限公司 | Nutritional compositions and methods for weaning from parenteral nutrition to enteral nutrition |
KR20120061162A (en) * | 2010-12-02 | 2012-06-13 | 대상 주식회사 | Beverage composition with improved stability and reduced browning |
CN103748115A (en) * | 2011-08-11 | 2014-04-23 | 旭化成化学株式会社 | Highly functional cellulose composite |
CN104114037A (en) * | 2012-02-14 | 2014-10-22 | 旭化成化学株式会社 | Cellulose composition |
CN104686667A (en) * | 2013-12-06 | 2015-06-10 | 内蒙古伊利实业集团股份有限公司 | Cereal milky beverage and preparation method thereof |
WO2015177145A1 (en) * | 2014-05-22 | 2015-11-26 | Nestec S.A. | Low-sugar dairy beverages |
CN105455133A (en) * | 2015-12-08 | 2016-04-06 | 西安力邦临床营养股份有限公司 | Predigestion type total nutrient solution and preparation method thereof |
CN105559050A (en) * | 2015-12-09 | 2016-05-11 | 南通励成生物工程有限公司 | Protolysate-based liquid food and preparation method |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109674038A (en) * | 2017-10-19 | 2019-04-26 | 江苏正大丰海制药有限公司 | A kind of oral complete nutritional composition |
CN113795565A (en) * | 2019-03-29 | 2021-12-14 | 切尔西科技有限公司 | Tracer compositions |
CN110973644A (en) * | 2019-12-16 | 2020-04-10 | 广州白云山汉方现代药业有限公司 | Casein and whey protein compounded nutritional suspension and preparation thereof |
CN114365841A (en) * | 2021-12-15 | 2022-04-19 | 北京诺康达医药科技股份有限公司 | Total nutrient milk suitable for patients with nephropathy and preparation method thereof |
CN114365841B (en) * | 2021-12-15 | 2024-04-19 | 北京诺康达医药科技股份有限公司 | Total nutrient milk suitable for nephrosis patients and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106974265A (en) | A kind of enteral nutritional composition | |
CN111194912B (en) | Stable medical liquid enteral nutrition composition and preparation method thereof | |
US8282965B2 (en) | Liquid nucleotides/nucleosides-containing product | |
EP2514321B1 (en) | Liquid food composition | |
JP5900347B2 (en) | Emulsified food composition | |
CN108464491A (en) | A kind of emulsion stabilizer and the pancebrin containing the emulsion stabilizer | |
CN106605709B (en) | Liquid milk suitable for children of 3-6 years old and preparation method thereof | |
CN108095088A (en) | Full nutrient formulation powder suitable for tumor patient rehabilitation and preparation method thereof | |
CN106234600A (en) | Solid beverage rich in DHA algal oil meal | |
CA2369175C (en) | Methods for stabilizing liquid nutritional products and products so stabilized | |
TWI434659B (en) | Induced viscosity nutritional emulsions comprising a carbohydrate-surfactant complex | |
CN115474690A (en) | Total-nutrient special medical application formula food emulsion taking plant whole protein as only protein source and preparation method thereof | |
CN106616959A (en) | Enteral nutrition preparation for patient in organ transplantation perioperative period and preparation method thereof | |
US9192573B2 (en) | Treatment method using liquid food composition | |
CN102342523A (en) | Preparation method for selenized carrageenan water-in-oil emulsion, and product and application of selenized carrageenan water-in-oil emulsion | |
WO2020245784A1 (en) | Composition for use in a method for prevention or treatment of maltnutrition in a subject suffering from a chronic inflammatory bowel diseases | |
JP6764933B2 (en) | Anionic-cationic polymers and soluble calcium stabilized in fructans | |
CN103859058B (en) | The high stability composition of a kind of whey protein | |
JP6488551B2 (en) | Nutritional composition | |
JP6019577B2 (en) | Method for producing liquid emulsion composition | |
CN117752089A (en) | Liquid fluid preparation suitable for limiting fat intake and preparation method thereof | |
CN112715668A (en) | A nutritional milk containing multiple minerals and its preparation method | |
CN102406102A (en) | Stabilizing agent composition and its application in liquid state milk for neonates to 6-month babies | |
WO2022163760A1 (en) | Gel-like nutritional composition | |
KR20240016254A (en) | nutritional composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170725 |
|
WD01 | Invention patent application deemed withdrawn after publication |